Algestone acetophenide
CAS: 24356-94-3
Ref. 3D-FA32126
1g | Ausgelaufen | ||
50mg | Ausgelaufen | ||
100mg | Ausgelaufen | ||
250mg | Ausgelaufen | ||
500mg | Ausgelaufen |
Produktinformation
- (16α)-16,17-[[(1R)-1-Phenylethylidene]bis(oxy)]pregn-4-ene-3,20-dione
- (4aR,4bS,6aS,6bS,8R,9aR,10aS,10bR)-6b-acetyl-4a,6a,8-trimethyl-8-phenyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- (4bS,6bS,9aR,10aS)-6b-acetyl-4a,6a,8-trimethyl-8-phenyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
- (R)-16alpha,17-((1-Phenylethylidene)dioxy)pregn-4-ene-3,20-dione
- (R)-16alpha,17-Dihydroxypregn-4-ene-3,20-dione cyclic acetal with acetophenone
- 16-alpha,17-Dihydroxypregn-4-ene-3,20-dione cyclic acetal with acetophenone
- 16-alpha,17-alpha-Dihydroxyprogesterone acetophenide
- 16alpha,17-((R)-1-Phenylethylidendioxy-4-pregnen-3,20-dion
- 16alpha,17alpha-Dihydroxyprogesterone acetophenone
- 2H-Naphth[1′,2′:6,7]indeno[1,2-d][1,3]dioxole, pregn-4-ene-3,20-dione deriv.
- Mehr Synonyme anzeigen
- Algesterone acetophenide
- Algeston acetofenid
- Algestoneacetophonide
- Alphasone acetophenide
- Deladroxone
- Dihydroxyprogesterone acetophenide
- Droxone
- Neolutin
- Neolutin Depositum
- P-Dhp
- Pregn-4-ene-3,20-dione, 16,17-((1-phenylethylidene)bis(oxy))-, (16alpha(R))-
- Pregn-4-ene-3,20-dione, 16,17-[(1-phenylethylidene)bis(oxy)]-, [16α(R)]-
- Pregn-4-ene-3,20-dione, 16,17-[[(1R)-1-phenylethylidene]bis(oxy)]-, (16α)-
- Pregn-4-ene-3,20-dione, 16-alpha,17-dihydroxy-, cyclic acetal with acetophenone, (R)-
- Pregn-4-ene-3,20-dione, 16α,17-dihydroxy-, cyclic acetal with acetophenone, (R)-
- Sq 15101
- Unii-Ol7Kc2O3Ot
- Zk 9349
Algestone acetophenide is a progestin that inhibits ovulation, which is the release of an egg from the ovary. It also prevents pregnancy by thickening cervical mucus and thinning the uterine lining. Algestone acetophenide is used in combination with estradiol benzoate as a contraceptive. Algestone acetophenide has been shown to have carcinogenic potential, specifically in fatty cells and in abdominal surgery patients. The compound has been shown to have physiological effects such as controlling blood pressure and regulating cholesterol levels. It also increases the risk of heart disease and stroke, especially in women who smoke or are over age 35.